HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: j.jacc.2006.11.045v1 49/14/1561    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Rowan, S. B. Articles by Anderson, R. J. Search for Related Content PubMed Articles by Rowan, S. B. Articles by Anderson, R. J.

CLINICAL RESEARCH: HEART RHYTHM DISORDER

Trends in Anticoagulation for Atrial Fibrillation in the U.S.

An Analysis of the National Ambulatory Medical Care Survey Database

Shane B. Rowan, MD^_*, Desiree N. Bailey, BS, Caroline E. Bublitz, MS and Robert J. Anderson, MD^_*,_*

^_* Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, Colorado
Department of Family Medicine, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado.

Manuscript received October 2, 2006; revised manuscript received November 20, 2006, accepted November 27, 2006.

^_* Reprint requests and correspondence: Dr. Robert J. Anderson, University of Colorado, Internal Medicine, 4200 East 9th Avenue, B178, Denver, Colorado 80262. (Email: robert.anderson{at}uchsc.edu).

Objectives: The purpose of this study was to track trends in the use of anticoagulation for atrial fibrillation (AF) over the past decade and identify predictors of use.

Background: Atrial fibrillation is common and associated with significant morbidity. Previous studies suggest underuse of anticoagulant therapy in patients with AF.

Methods: The National Ambulatory Medical Care Survey database was queried for all patient visits with a diagnosis of AF between 1994 and 2003. Other diagnoses, other medications, and demographic, visit, geographic, and provider characteristics were compared with the prescription of anticoagulation in predefined age and risk groups.

Results: The prevalence of the diagnosis of AF and anticoagulation for AF has increased over the last decade. Increased age and use of rate control agents is associated with the use of anticoagulation. There is a trend toward less anticoagulation when a rhythm control agent is used instead of a rate control agent. Anticoagulation might be overused in a group of low-risk patients.

Conclusions: From 1995 through 2002, an increase has occurred in anticoagulation for AF, especially in those at highest risk for thromboembolic phenomena. A substantial number of patients at risk for thromboembolic events are not anticoagulated, and further studies are needed to determine how many of these patients are candidates for anticoagulation. Anticoagulation use has increased in nontargeted, low-risk groups in whom antiplatelet agents are appropriate. Use of a rhythm control agent might be associated with less use of anticoagulation.

Abbreviations and Acronyms   AF = atrial fibrillation   NAMCS = National Ambulatory Medical Care Survey   NCHS = National Center for Health Statistics